See more : Eupraxia Pharmaceuticals Inc. (EPRXF) Income Statement Analysis – Financial Results
Complete financial analysis of Broad Capital Acquisition Corp. (BRAC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Broad Capital Acquisition Corp., a leading company in the Shell Companies industry within the Financial Services sector.
- SGS SA (0QMI.L) Income Statement Analysis – Financial Results
- Progress Acquisition Corp. (PGRWU) Income Statement Analysis – Financial Results
- Kwality Pharmaceuticals Limited (KPL.BO) Income Statement Analysis – Financial Results
- National Tyre & Wheel Limited (NTD.AX) Income Statement Analysis – Financial Results
- Leofoo Development Co., Ltd. (2705.TW) Income Statement Analysis – Financial Results
Broad Capital Acquisition Corp. (BRAC)
Industry: Shell Companies
Sector: Financial Services
About Broad Capital Acquisition Corp.
Broad Capital Acquisition Corp focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to focus on businesses in the general aviation and aerospace industry, and the unmanned aircraft systems and advanced air mobility industries in the United States and internationally. The company was incorporated in 2021 and is based in Plano, Texas.
Metric | 2023 | 2022 | 2021 |
---|---|---|---|
Revenue | 0.00 | 1.51M | 0.00 |
Cost of Revenue | 2.41M | 1.51M | 0.00 |
Gross Profit | -2.41M | 0.00 | 0.00 |
Gross Profit Ratio | 0.00% | 0.00% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 |
SG&A | 2.41M | 1.51M | 20.10K |
Other Expenses | 200.00K | 1.70M | -20.10K |
Operating Expenses | 2.61M | 1.70M | 20.10K |
Cost & Expenses | 2.61M | 1.70M | 20.10K |
Interest Income | 2.75M | 1.56M | 0.00 |
Interest Expense | 120.23K | 0.00 | 0.00 |
Depreciation & Amortization | 2.75M | 1.70M | 30.14K |
EBITDA | 142.52K | -1.70M | 10.05K |
EBITDA Ratio | 0.00% | -112.94% | 0.00% |
Operating Income | -2.61M | -1.70M | -20.09K |
Operating Income Ratio | 0.00% | -112.94% | 0.00% |
Total Other Income/Expenses | 2.63M | 1.56M | 0.00 |
Income Before Tax | 22.29K | -147.95K | -20.10K |
Income Before Tax Ratio | 0.00% | -9.81% | 0.00% |
Income Tax Expense | 536.21K | 285.66K | -30.14 |
Net Income | -513.92K | -433.62K | -20.10K |
Net Income Ratio | 0.00% | -28.75% | 0.00% |
EPS | -0.06 | -0.03 | 0.00 |
EPS Diluted | -0.06 | -0.03 | 0.00 |
Weighted Avg Shares Out | 8.55M | 13.00M | 13.15M |
Weighted Avg Shares Out (Dil) | 8.55M | 13.00M | 13.15M |
Broad Capital Acquisition Corp Confirms Funding to Extend Period to Consummate Initial Business Combination to June 13, 2024
Broad Capital Acquisition Corp Confirms Funding to Extend Period to Consummate Initial Business Combination to May 13, 2024
Broad Capital Acquisition Corp Confirms Funding to Extend Period to Consummate Initial Business Combination to April 13, 2024
Broad Capital Acquisition Corp Confirms Funding to Extend Period to Consummate Initial Business Combination to March 13, 2024
Broad Capital Acquisition Corp Confirms Funding to Extend Period to Consummate Initial Business Combination to February 13, 2024
Broad Capital Acquisition Corp Confirms Funding to Extend Period to Consummate Initial Business Combination to January 13, 2024
Broad Capital Acquisition Corp Confirms Funding to Extend Period to Consummate Initial Business Combination to December 13, 2023
Broad Capital Acquisition Corp Confirms Funding to Extend Period to Consummate Initial Business Combination to November 13, 2023
Broad Capital Acquisition Corp Confirms Funding to Extend Period to Consummate Initial Business Combination to October 13, 2023
Broad Capital Acquisition Corp Confirms Funding to Extend Period to Consummate Initial Business Combination to September 13, 2023
Source: https://incomestatements.info
Category: Stock Reports